Everett Harris & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.9M Buy
124,689
+68,749
+123% +$18.1M 0.43% 33
2026
Q1
$14.9M Buy
55,940
+17,937
+47% +$4.86M 0.19% 49
2025
Q4
$9.53M Buy
38,003
+3,722
+11% +$989K 0.12% 53
2025
Q3
$9.84M Sell
34,281
-505
-1% -$135K 0.12% 54
2025
Q2
$9.13M Buy
34,786
+2,245
+7% +$547K 0.12% 53
2025
Q1
$7.57M Buy
32,541
+187
+0.6% +$45.4K 0.1% 58
2024
Q4
$7.42M Buy
32,354
+1,840
+6% +$422K 0.09% 60
2024
Q3
$6.82M Buy
30,514
+1,260
+4% +$277K 0.08% 65
2024
Q2
$5.95M Buy
29,254
+5,678
+24% +$1.16M 0.08% 67
2024
Q1
$5.15M Buy
23,576
+4,873
+26% +$1.07M 0.07% 70
2023
Q4
$4.25M Buy
18,703
+5,190
+38% +$1.09M 0.06% 71
2023
Q3
$2.72M Buy
13,513
+749
+6% +$158K 0.04% 84
2023
Q2
$2.65M Sell
12,764
-30
-0.2% -$5.82K 0.04% 85
2023
Q1
$2.52M Buy
12,794
+48
+0.4% +$9.88K 0.04% 86
2022
Q4
$2.58M Sell
12,746
-87
-0.7% -$17K 0.04% 80
2022
Q3
$2.26M Hold
12,833
0.04% 86
2022
Q2
$2.58M Hold
12,833
0.04% 85
2022
Q1
$2.91M Sell
12,833
-58
-0.4% -$13.6K 0.04% 86
2021
Q4
$3.48M Hold
12,891
0.05% 83
2021
Q3
$3.12M Sell
12,891
-59
-0.5% -$14.9K 0.05% 82
2021
Q2
$3.07M Sell
12,950
-1,193
-8% -$272K 0.05% 82
2021
Q1
$3.1M Sell
14,143
-174
-1% -$34.9K 0.05% 79
2020
Q4
$2.5M Sell
14,317
-262
-2% -$45.3K 0.04% 82
2020
Q3
$2.36M Sell
14,579
-1,193
-8% -$189K 0.05% 88
2020
Q2
$2.25M Sell
15,772
-58
-0.4% -$8.02K 0.05% 86
2020
Q1
$1.72M Buy
15,830
+785
+5% +$113K 0.04% 94
2019
Q4
$2.19M Hold
15,045
0.05% 106
2019
Q3
$2.17M Hold
15,045
0.05% 99
2019
Q2
$2.23M Sell
15,045
-2,619
-15% -$365K 0.06% 96
2019
Q1
$2.32M Sell
17,664
-320
-2% -$39.4K 0.06% 94
2018
Q4
$1.95M Hold
17,984
0.06% 94
2018
Q3
$2.68M Sell
17,984
-58
-0.3% -$8.82K 0.07% 83
2018
Q2
$2.78M Sell
18,042
-87
-0.5% -$13.1K 0.08% 78
2018
Q1
$2.52M Buy
18,129
+1,338
+8% +$197K 0.07% 85
2017
Q4
$2.3M Sell
16,791
-1,862
-10% -$246K 0.06% 95
2017
Q3
$2.42M Sell
18,653
-233
-1% -$31.1K 0.07% 93
2017
Q2
$2.5M Hold
18,886
0.08% 88
2017
Q1
$2.33M Sell
18,886
-698
-4% -$82.6K 0.08% 88
2016
Q4
$2.16M Sell
19,584
-1,630
-8% -$181K 0.08% 93
2016
Q3
$2.51M Sell
21,214
-1,048
-5% -$123K 0.09% 95
2016
Q2
$2.49M Sell
22,262
-1,746
-7% -$188K 0.09% 93
2016
Q1
$2.42M Sell
24,008
-2,357
-9% -$226K 0.09% 99
2015
Q4
$2.8M Sell
26,365
-2,456
-9% -$253K 0.1% 90
2015
Q3
$2.69M Sell
28,821
-931
-3% -$96.3K 0.1% 91
2015
Q2
$3.1M Sell
29,752
-873
-3% -$90.9K 0.11% 81
2015
Q1
$3.32M Sell
30,625
-4,656
-13% -$479K 0.11% 77
2014
Q4
$3.27M Sell
35,281
-74,121
-68% -$6.55M 0.11% 78
2014
Q3
$9.56M Sell
109,402
-17,838
-14% -$1.61M 0.34% 47
2014
Q2
$11.2M Sell
127,240
-31,661
-20% -$2.74M 0.41% 46
2014
Q1
$13.4M Sell
158,901
-107,554
-40% -$8.58M 0.5% 41
2013
Q4
$20.9M Sell
266,455
-6,140
-2% -$524K 0.78% 34
2013
Q3
$23.2M Buy
272,595
+20,044
+8% +$1.69M 0.95% 31
2013
Q2
$21.7M Buy
+252,551
New +$21M 0.91% 32

Other funds holding LH

Everett Harris & Co's LH Position: Q2 2026 in Review

Everett Harris & Co increased its Labcorp (LH) stake by 123% in Q2 2026, buying an estimated $18.1M and bringing the position to 124,689 shares worth $34.9M. The position accounts for 0.43% of the portfolio, ranked #33.

Everett Harris & Co first reported a position in LH in Q2 2013 and has held it in 53 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Everett Harris & Co held 124,689 shares of Labcorp worth $34.9M as of Q2 2026.
  • Everett Harris & Co bought 68,749 Labcorp shares in Q2 2026, an estimated $18.1M.
  • Labcorp made up 0.43% of Everett Harris & Co's portfolio in Q2 2026, its #33 holding.
  • Everett Harris & Co first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.